Ayuda
Ir al contenido

Dialnet


Salivary biomarkers present in patients with periodontitis without clinical distinction: findings from a meta-analysis

    1. [1] Universidad Federal de Pará

      Universidad Federal de Pará

      Brasil

    2. [2] Laboratory of Histological Analysis and Preparation (LAPHis), Parnaiba Delta Federal University (UFDPar), Parnaiba, Brazil
    3. [3] Laboratory of Pain neuromodulation and sensorimotor performance, (LANDS), Parnaiba Delta Federal University (UFDPar), Parnaíba, Brazil
    4. [4] Parnaiba Delta Federal University
    5. [5] Laboratory of Infectious Diseases (LADIC), Parnaiba Delta Federal University (UFDPar), Parnaíba, Brazil
    6. [6] Advanced Study Group in Mycology, Parnaiba Delta Federal University (UFDPar), Parnaíba, Brazil
  • Localización: Medicina oral, patología oral y cirugía bucal. Ed. inglesa, ISSN-e 1698-6946, Vol. 28, Nº. 5 (September), 2023
  • Idioma: inglés
  • Enlaces
  • Resumen
    • A new classification for periodontitis has been adopted in clinical practice. However, there are still discussions regarding this new classification and difficulties in its adoption, both by professionals and researchers. Thus, this study aimed to evaluate which salivary biomarkers are present in periodontitis, following the new classification of periodontal diseases through meta-analysis.

      A literature search was carried out in the scientific databases: PubMed, Scielo and Google scholar to select studies. The selection of studies was followed by two authors upon reading of the title, abstract and full text. The necessary data were collected and statistical analyses were performed using the Review Manager statistical software version 5.4, with calculation of Mean Difference, heterogeneity (I²) and funnel plot with P < 0.05.

      After following the selection criteria, 9 articles were selected for comparison. The studies address the presence of biomarkers in the saliva of patients with periodontitis and their possible use in the monitoring and diagnosis of the disease. For the meta-analytic comparison, a sample size of 1,983 individuals was used. Statistical analyses showed that nitric oxide, IL-6, IL-1B and osteoprotegerin are substances that are significantly present in patients with periodontitis (P < 0.05).

      IL-6, nitric oxide, IL-1B, TNF-α and osteoprotegerin are among the most present biomarkers in patients with periodontitis, and may be used in the future as a monitoring of periodontal disease. The present study also revealed that there was no statistically significant difference in the concentration of these biomarkers for clinical distinction from periodontitis.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno